Document detail

Food and Drugs Authority (FDA), Ghana (2016)   C2


Document No. : FDA/SMC/SMD/GL-RAR/2013/01

pharmacovigilance,  adverse reactions,  National Guidelines,  clinical trials,  drug safety,  adverse drug reactions,